Evaluation of Micro-osteoperforation on Rate of Maxillary En-masse Retraction

December 5, 2018 updated by: Nashwa abdel mohsen mohamed, Cairo University

Evaluation of Micro-osteoperforation on Rate of Maxillary En-masse Retraction: A Randomized Controlled Trial

accelerated anterior teeth retraction with the help of microosteoperforation procedure and miniscrews.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

the study contains 2 groups each contains 13 subjects, A control group (anterior segment retraction with the help of miniscrews) and an intervention group ( anterior segment retraction with the help of miniscrews and microosteoperforation)

Study Type

Interventional

Enrollment (Anticipated)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Giza
      • Cairo, Giza, Egypt, 12566
        • Cairo university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 30 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Females with an age ranging between 16-30 years.
  • Malocclusion that requires bilateral extraction of the maxillary first premolars and anterior segment retraction; Angle class I mal-occlusion with bi-alveolar dental protrusions or class II division 1.
  • Healthy dental and periodontal condition with a good oral hygiene
  • Absence of degenerative conditions.
  • Full set of permanent dentition.

Exclusion Criteria:

  • Medically compromised patients.
  • Previous orthodontic treatment
  • Patients suffering from any congenital, hereditary or systemic diseases or asymmetries that might have an influence on tooth movement
  • Chronic use of any medications affecting orthodontic tooth movement (eg: NSAIDs).
  • Active periodontal affection or severe gingival inflammation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: en masse retraction only
anterior segment retraction on miniscrews without microosteoperforation
Active Comparator: en masse retraction with alveocentesis
anterior segment retraction on miniscrews with microosteoperforation
small holes made using large round bur
Other Names:
  • accelerated tooth movement
  • alveocentesis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of En-masse retraction
Time Frame: three to six months
retracting six anterior teeth
three to six months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Root resorption affecting the six anterior teeth.
Time Frame: three to six months
Amount of root volume loss analyzed through CBCT software
three to six months
Tipping affecting the anterior teeth.
Time Frame: three to six months
Changes in angular measurements calculated through CBCT software
three to six months
Extrusion of anterior teeth
Time Frame: three to six months
Linear measurement changes in the clinical height using CBCT
three to six months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mohamed A Kaddah, Phd, cairo U

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2019

Primary Completion (Anticipated)

November 1, 2020

Study Completion (Anticipated)

November 1, 2020

Study Registration Dates

First Submitted

December 1, 2018

First Submitted That Met QC Criteria

December 3, 2018

First Posted (Actual)

December 5, 2018

Study Record Updates

Last Update Posted (Actual)

December 7, 2018

Last Update Submitted That Met QC Criteria

December 5, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

All patients' personal data of the patient will be kept safely and no patient data will be used outside the trial unless approved by the patient.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Class II Division 1 Malocclusion

Clinical Trials on microosteoperforation

Subscribe